Related Experiment Videos
Developing protocols for recombinant adeno-associated virus-mediated gene therapy in space
1Dept. of Biochemistry & Molecular Biology, Center for Sickle Cell Disease, Howard University, Washington, DC, USA.
Journal of Gravitational Physiology : a Journal of the International Society for Gravitational Physiology
|April 17, 2003
Summary
Gene therapy using adeno-associated virus serotype 2 (AAV2) shows promise for treating beta-thalassemia and sickle cell anemia. This research aims to develop space-suitable gene therapy protocols for astronauts and Earth-bound patients.
Area of Science:
- Biomedical research
- Gene therapy
- Space medicine
Background:
- Genetic blood disorders like beta-thalassemia and sickle cell anemia require effective treatments.
- Gene therapy offers a potential solution for these conditions, with applications extending to space exploration challenges.
- Adeno-associated virus serotype 2 (AAV2) is a suitable vector for gene delivery due to its non-pathogenic nature and broad tissue specificity.
Purpose of the Study:
- To develop gene therapy protocols for hemoglobinopathies, specifically beta-thalassemia and sickle cell anemia.
- To create gene therapy methods applicable to both terrestrial and space environments.
- To utilize AAV2 for developing recombinant AAV2 (rAAV)-based gene therapy.
Main Methods:
- Developing rAAV constructs and hematopoietic stem cell (HSC) culture systems.
- Utilizing HSC transplantation (HST) and gene therapy to treat a mouse model of beta-thalassemia.
- Employing AAV2's characteristics for targeted gene delivery.
Main Results:
- Established protocols for rAAV-based gene therapy.
- Demonstrated the potential of gene therapy in a mouse model of beta-thalassemia.
- Developed a foundation for applying gene therapy to space-related health issues.
Conclusions:
- rAAV-based gene therapy is a viable approach for treating hemoglobinopathies.
- The developed gene therapy protocols have potential applications for astronauts and patients on Earth.
- This research paves the way for advanced gene therapies in challenging environments.